BioMarin Pharmaceutical (BMRN) — Rating History

Complete AI committee score history · 15 sessions recorded · Updated nightly

← Overview📈 Rating History💰 Earnings📰 Recent Events🔄 What Changed📖 Thesis Evolution🔍 Similar Stocks
DateScoreRatingRecommendationConvictionAgreementAnalysts
2026-08-0157.6BuyWatchContested57%7
2026-07-3157.1BuyWatchContested57%7
2026-07-3058.4BuyWatchContested57%7
2026-07-2957.0BuyWatchContested57%7
2026-07-2857.0BuyWatchContested57%7
2026-07-2758.7BuyWatchContested57%7
2026-07-2658.7BuyWatchContested57%7
2026-07-2557.0BuyWatchModerate60%5
2026-07-2457.0BuyWatchModerate60%5
2026-07-2357.2BuyWatchContested57%7
2026-07-2257.2BuyWatchContested57%7
2026-07-2156.7BuyWatchContested57%7
2026-07-2056.7BuyWatchContested57%7
2026-07-1956.7BuyWatchContested57%7
2026-07-1857.0BuyWatchContested57%7

About This Data

Committee scores are generated nightly by Innellis's 7-analyst AI committee. Each session analysts independently score BioMarin Pharmaceutical across fundamentals, momentum, and risk — then debate and reach a consensus. Scores range from 0 (most bearish) to 100 (most bullish). View track record →